SUCLG2-AS1

Across TCGA pan-cancer cohorts, SUCLG2-AS1 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated SUCLG2-AS1 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher SUCLG2-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated SUCLG2-AS1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and KIRC show a favorable association.

SKCM, KIRC, and UCS are the cancer types where SUCLG2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	II,III,IV	0.366	0.198	<.001	48	view →
KIRC	DFS	Median	All	0.737	0.534	<.001	45	view →
UCS	DFS	Median	IV	0.952	0.367	.001	36	view →
LGG	OS	Median	All	0.751	0.870	<.001	34	view →
KICH	DFS	Quartile	II,III,IV	0.453	0.944	.003	33	view →
CESC	DFS	Tertile	All	0.612	0.804	.001	26	view →
HNSC	DFS	Tertile	All	0.758	0.640	.019	10	view →
PRAD	DFS	Quartile	All	0.952	0.872	.016	10	view →
SARC	OS	Tertile	All	0.844	0.618	.004	9	view →
BRCA	DFS	Tertile	III,IV	0.913	0.820	.018	8	view →
LUSC	OS	Median	IV	0.255	0.851	.021	6	view →
UCEC	OS	Median	All	0.842	0.900	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

SUCLG2-AS1–SKCM (OS)

Open the SKCM breakdown →